Company profile
NanoTess
Transforming skin and wound care with proprietary catalytic technology, CTM. Proudly made in Canada 🍁
- Industry
- Biotechnology Research
- Employees
- 24
- Headquarters
- Calgary, Alberta
- Founded
- 2020
- LinkedIn followers
- 3,160
- Office locations
- 1
NanoTess company summary
NanoTess is a company in the Biotechnology Research industry, headquartered in Calgary, Alberta, founded in 2020. On LinkedIn the company has around 24 employees and 3,160 followers. Its listed specialties include Catalysts, Catalytic Innovation, Advanced Wound Treatment, Antimicrobial, skin care.
What technology does NanoTess use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NanoTess
NanoTess was co-founded in Calgary, Alberta, in 2020 to change the way physicians, healthcare systems, patients, and caregivers treat chronic, traumatic, and acute wounds and skin conditions. NanoTess’ first commercialized technology, CTM, enables the body's natural healing progression and copper-dependent cellular signalling. It optimizes, amplifies, and accelerates existing healing processes, which can become disrupted by aging, illness, or comorbidities. CTM is commercially available in NanoSALV Catalytic, which was authorised by Health Canada in 2022 and has been adopted by some of Canada’s biggest healthcare systems including AHS and BC Provincial Health Services Authority. It was added to the Alberta Drug Benefit List for coverage in August 2025. NanoSALV Catalytic, powered by CTM, is currently accessible across 2,500 hospitals and healthcare facilities and 14,000 pharmacies, across Canada. Due to the nature of catalysts, NanoSALV Catalytic is classed as a medical device, not a drug, and is an entirely new treatment category for healthcare systems. NanoTess is built on social enterprise values with a mission to leave no-one behind. Through our Heal One, Heal Another community healing and compassionate care program, we support non-profits, communities, and individuals to access innovation and reduce barriers to care.
Specialties
Where is NanoTess located?
NanoTess lists 1 location.
Compare companies similar to NanoTess
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NanoTess nanotess.com | Biotechnology Research | 24 | 2020 | Calgary, Alberta |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NanoTess
What does NanoTess do?
NanoTess was co-founded in Calgary, Alberta, in 2020 to change the way physicians, healthcare systems, patients, and caregivers treat chronic, traumatic, and acute wounds and skin conditions. NanoTess’ first commercialized technology, CTM, enables the body's natural healing progression and copper-dependent cellular signalling. It optimizes, amplifies, and accelerates existing healing processes, which can become disrupted by aging, illness, or comorbidities. CTM is commercially available in NanoSALV Catalytic, which was authorised by Health Canada in 2022 and has been adopted by some of Canada’s biggest healthcare systems including AHS and BC Provincial Health Services Authority. It was added to the Alberta Drug Benefit List for coverage in August 2025. NanoSALV Catalytic, powered by CTM, is currently accessible across 2,500 hospitals and healthcare facilities and 14,000 pharmacies, across Canada. Due to the nature of catalysts, NanoSALV Catalytic is classed as a medical device, not a drug, and is an entirely new treatment category for healthcare systems. NanoTess is built on social enterprise values with a mission to leave no-one behind. Through our Heal One, Heal Another community healing and compassionate care program, we support non-profits, communities, and individuals to access innovation and reduce barriers to care.
How many employees does NanoTess have?
NanoTess has around 24 employees on LinkedIn.
Where is NanoTess headquartered?
NanoTess is headquartered in Calgary, Alberta.
When was NanoTess founded?
NanoTess was founded in 2020.
Build a lead list from companies like NanoTess
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.